Stock search

Ticker or company name

BSX card

BSX price forecast

Boston Scientific$43,69

P/E now is 18,5. Average over 5 years: 65,7 (range 58–82). The stock is 72% below its history.

Base · FY2030

$172,36+39,5% a year

The base case gives 39,5% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$23,1 bn$26,6 bn$30,7 bn$35,3 bn$40,7 bn
Net income$2,35 bn$2,71 bn$3,12 bn$3,59 bn$4,14 bn
EPS$1,56$1,77$2,02$2,30$2,62

Changed values are highlighted. Bear and bull cases: growth ∓ 5,7%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $43,69

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$94,61

Price change
+116,6%
A year
+20,6%
Fair value today
$63,89
Margin of safety
+46,2%

Base$172,36

Price change
+294,5%
A year
+39,5%
Fair value today
$116,39
Margin of safety
+166,4%

Bull$328,71

Price change
+652,4%
A year
+63,2%
Fair value today
$221,97
Margin of safety
+408,1%

What growth the price implies

For the stock to return 10% a year, revenue must grow −5,3% a year to FY2030 at a 10,2% margin and P/E 65,7.

Growth over 5 years
15,2%
Analyst consensus
no data
In your model
15,2%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$172,36+39,5% a year